| Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) EA Klein, IM Thompson, CM Tangen, JJ Crowley, MS Lucia, PJ Goodman, ... Jama 306 (14), 1549-1556, 2011 | 2054 | 2011 |
| A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma F Saad, DM Gleason, R Murray, S Tchekmedyian, P Venner, L Lacombe, ... Journal of the National Cancer Institute 94 (19), 1458-1468, 2002 | 2050 | 2002 |
| Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer F Saad, DM Gleason, R Murray, S Tchekmedyian, P Venner, L Lacombe, ... Journal of the National Cancer Institute 96 (11), 879-882, 2004 | 1450 | 2004 |
| Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial IM Thompson, CM Tangen, J Paradelo, MS Lucia, G Miller, D Troyer, ... The Journal of urology 181 (3), 956-962, 2009 | 1392 | 2009 |
| Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial IM Thompson, CM Tangen, J Paradelo, MS Lucia, G Miller, D Troyer, ... Jama 296 (19), 2329-2335, 2006 | 1026 | 2006 |
| Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial MR Smith, F Saad, R Coleman, N Shore, K Fizazi, B Tombal, K Miller, ... The Lancet 379 (9810), 39-46, 2012 | 942 | 2012 |
| Intermittent androgen suppression for rising PSA level after radiotherapy JM Crook, CJ O'Callaghan, G Duncan, DP Dearnaley, CS Higano, ... New England Journal of Medicine 367 (10), 895-903, 2012 | 534 | 2012 |
| Active surveillance of small renal masses: progression patterns of early stage kidney cancer MAS Jewett, K Mattar, J Basiuk, CG Morash, SE Pautler, DR Siemens, ... European urology 60 (1), 39-44, 2011 | 525 | 2011 |
| Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis AJ Abusamra, Z Zhong, X Zheng, M Li, TE Ichim, JL Chin, WP Min Blood Cells, Molecules, and Diseases 35 (2), 169-173, 2005 | 474 | 2005 |
| Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial JLS Au, RA Badalament, MG Wientjes, DC Young, JA Warner, ... Journal of the National Cancer Institute 93 (8), 597-604, 2001 | 399 | 2001 |
| Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis E Winquist, TS Kirchner, R Segal, J Chin, H Lukka The Journal of urology 171 (2), 561-569, 2004 | 377 | 2004 |
| Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma ME Gleave, M Elhilali, Y Fradet, I Davis, P Venner, F Saad, LH Klotz, ... New England journal of medicine 338 (18), 1265-1271, 1998 | 367 | 1998 |
| Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects ME GLEAVE, SL GOLDENBERG, JL CHIN, J WARNER, F SAAD, ... The Journal of urology 166 (2), 500-507, 2001 | 353 | 2001 |
| Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer W Xie, MM Regan, M Buyse, S Halabi, PW Kantoff, O Sartor, H Soule, ... Journal of Clinical Oncology 35 (27), 3097-3104, 2017 | 343 | 2017 |
| Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794 GP Swanson, MA Hussey, CM Tangen, J Chin, E Messing, ... Journal of Clinical Oncology 25 (16), 2225-2229, 2007 | 325 | 2007 |
| Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone‐refractory prostate cancer JB Nelson, W Love, JL Chin, F Saad, CC Schulman, DJ Sleep, J Qian, ... Cancer 113 (9), 2478-2487, 2008 | 269 | 2008 |
| Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer V Chalasani, JL Chin, JI Izawa Canadian Urological Association Journal 3 (6 Suppl 4), S193, 2009 | 238 | 2009 |
| Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy LH Klotz, SL Goldenberg, MAS Jewett, Y Fradet, R Nam, J Barkin, J Chin, ... The Journal of urology 170 (3), 791-794, 2003 | 224 | 2003 |
| Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications JL CHIN, SE PAUTLER, V MOURAVIEV, N TOUMA, K MOORE, ... The Journal of urology 165 (6 Part 1), 1937-1942, 2001 | 209 | 2001 |
| Vascular‐targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses J Trachtenberg, RA Weersink, SRH Davidson, MA Haider, A Bogaards, ... BJU international 102 (5), 556-562, 2008 | 196 | 2008 |
Glenn BaumanProfessor, Department of Oncology, Western UniversityVerified email at lhsc.on.ca
